Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP)

Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP)

US Patent 7115380 · Granted Oct 3, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ligand controling interaction between gags with their effector molecules and use2022
Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 2020
Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneratio2020
Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neur2019
Use of a reverse-transcriptase inhibitor in the prevention and treatment of dege2018
Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neur2018
Inhibition of the synthesis of beta-app or the activity of the A-β peptide in th2018
Use of the engrailed homeodomain protein as anxiolytic2013
Carrier vectors through an epithelium with tight junctions2012
Uses of peptides derived from the cytoplasmic domain of the amyloid protein prec2005
Uses of peptides derived from the cytoplasmic domain of the amyloid protein prec2005
Method for identification of target genes of transcription factors2003